BAR HARBOR, Maine — Over the past year, billions of dollars and countless hours of research have gone into developing a vaccine for COVID-19.
Not every virus, illness, or disease gets that kind of attention. Rare diseases receive relatively little attention and investment from pharmaceutical companies.
By United States standards, a “rare and orphan disease” is one that affects fewer than 200,000 people. Read more
FORT KENT, Maine — Fort Kent middle schoolers are the state’s first students to learn at the newly unveiled Maine Mobile Biolab, a 50-foot,...
Anew medical lab training facility on the campus of University of Maine Augusta is nearly six times larger than an off-campus space...
The University of New England has received a grant from the Maine Department of Inland Fisheries and Wildlife to study one...